Business Board Advisor
Rob Rueckert joined joined Cyrcadia as a Business Advisory Board Advisor in 2015. He currently with Sorenson Capital which he joined in 2015 to further expand its existing growth-stage technology practice. Since joining Sorenson Capital, he has lead investments in RealtyMogul (alternative commercial real estate lending platform) and Couchbase (NoSQL database software).
Prior to joining Sorenson, Rob spent 14 years at Intel Capital based in Silicon Valley and was a managing director in the consumer technology segment (IoT, wearables, drones, etc..). Rob was a voting member of Intel Capital’s investment committee.
During his tenure at Intel Capital he invested in more than 50 companies across multiple technology sectors (enterprise software, consumer internet, gaming, security, communications, cloud computing and data platforms) and geographies (North America, China, Western and Eastern Europe, India, Israel and New Zealand). Rob was responsible for identifying transformative technology companies where he could invest and work alongside the management teams, primarily in a board capacity, to help the companies grow towards a successful outcome.
At Intel Capital, Rob managed and oversaw more than 25 successful exits from his portfolio, including 4 IPOs and acquisitions by Oracle, Cisco, Microsoft, Fidelity, American Express, Intel and Telefonica.
Some highlights of his investment portfolio include Accertify (acquired by American Express), Perceptive Pixel (acquired by Microsoft) and Datallegro (acquired by Microsoft) as well as active companies Kabam, Nexmo and Betaworks.
Prior to joining Intel Capital, Rob worked as a technology consultant for Arthur Andersen and has worked for several companies in executive roles. Rob has an MBA from the University of Chicago, a bachelor’s degree in information systems from Brigham Young University and is a Kauffman Fellow.
Business Board Advisor
Mandy is a Sports Business Analyst, Entrepreneur, and Columnist for Inc. Magazine. She serves as an Executive Board Member, Investor and Advisor to sports business companies, and as an Advisor to professional and retired professional athletes. As the Creator and Author of ChangeUp, LLC, Mandy builds companies and authors stories that help “progress the game”.
As a former marketing and advertising executive, Mandy grew to become one of the youngest Executive Vice Presidents in the industry, holding executive-level positions in two of the three largest communications holding companies in the world − Omnicom and Publicis Worldwide.
She built, managed and oversaw teams and operations in 12 countries, and led the creation of award winning strategies and communications for multi-million dollar global businesses, such as Hilton Worldwide, LG Electronics, the Olympics and US Open Tennis. During her tenure, Mandy participated in the holding company’s acquisition process of small agencies and startups, and was selected to attend and completed the Graduate Leadership Program at Babson College in conjunction with Harvard Business School.
Mandy advises on policy and advocacy surrounding sports for social change, and sports and domestic violence in conjunction with the NFL and MLB, in her role as a Leadership Committee Member for the non-profit organization Futures Without Violence. She is also a collaborator for their youth program, “Coaching Boys into Men”, (a global training program for high school athletic coaches), together with Coaches Mike Krzyzewski, Pete Carroll, Joe Torre and the late Dean Smith.
In addition to Inc. Magazine, Mandy’s published works are featured in outlets such as Business Insider, Forbes, Huffington Post, Yahoo Finance, Yahoo Sports, and as curriculum at Universities & Colleges nation-wide where she often keynotes. She has also been a featured guest on ESPN Radio, and various sports, entrepreneurial and sports business podcasts.
As a former collegiate athlete, Mandy can usually be found at anything with a scoreboard, or running along the Hudson in New York City, where she resides.
Joshua Ellenhorn, MD
Principal Investigator Clinical Trials, Cedars-Sinai Hospital, Los Angeles, CA
Joshua D.I. Ellenhorn, MD, serves as the Lead Principal Investigator for our upcoming multi-center clinical validation trail. Dr. Ellenhorn is a leading expert in Surgical Oncology, specializing in the surgical treatment of cancer. He is Clinical Professor of Surgery at Cedars-Sinai Medical Center and Adjunct Professor at the John Wayne Cancer Center. He is ranked by US News & World Report among the top 1% of Surgeons in the United States and ranked as a Super Doctor in Los Angeles. He is a medical educator, having trained over 60 surgical oncologists. A nationally recognized leader in surgery, surgical education, and cancer research, Dr. Ellenhorn is dedicated to providing the highest quality of surgical care with an emphasis on a personalized approach to the individual patient.
Dr. Ellenhorn practiced for over 18 years at the City of Hope National Medical Center and was Professor and Chief of the Division of General and Oncologic Surgery and was director of the nationally recognized Surgical Oncology Training Program. His many achievements include pioneering the use of minimally invasive and robotic techniques to treat gastrointestinal malignancies. He has been in the forefront of breast cancer treatment, promoting highly innovative techniques such as intraoperative radiation therapy and skin and nipple sparing techniques for breast cancer treatment. In addition to his clinical and educational work, Dr. Ellenhorn directed an active research laboratory. His laboratory worked to develop new cancer vaccines that can stimulate the immune system to identify and eliminate cancer cells.
William B. Farrar, MD
Medical Board Advisor, Principle Investigator - The Ohio State University JamesCare Comprehensive Breast Center
William B. Farrar, MD, The Dr. Arthur G. and Mildred C. James Professor in Surgical Oncology and chief, Division of Surgical Oncology, and director of the new 220,000 square foot JamesCare Comprehensive Breast Center is the sponsor for Cyrcadia Health’s final validation clinical trial.
Dr. Farrar is one of the nation’s foremost experts in breast cancer detection and treatment, as well as a leader in the central Ohio cancer community. Having trained as a surgical resident under Dr. Arthur G. James, the founder and namesake of our cancer hospital, Dr. Farrar has played an invaluable role in Ohio State’s emergence as a national leader in cancer care.
Working with physicians and administrators throughout the breast cancer program, Dr. Farrar has develop and implement the clinical vision and strategy for the Center. He oversees all aspects of clinical breast services and ensure the delivery of multidisciplinary, multimodality care in one location. He is also be responsible for continued improvement of patient outcomes and for the creation of a unique patient experience that boosts satisfaction levels and exceeds quality and safety goals. Finally, as the originator for the initial Cyrcadia Health trial, Dr. Farrar will see the final successful patient testing completed leading to Cyrcadia Health’s FDA clinical 510K filing in late 2014.
Dr. Imtiaz Qureshi
Principal Investigator - Medical Director and Chief of Radiology, El Camino Hospital, Mt. View CA
Dr. Imtiaz Qureshi is the Chief of Imaging and Medical Director at El Camino Hospital. He trained at elite Institutions like Yale University and Stanford University. He specializes in Oncologic Imaging and Neuroradiology. His special interest is early cancer detection and development of cutting edge medical devices in Imaging. He is Principal Investigator of several Clinical Trials in the Early Cancer Detection field.
Barb Dehn, RN, MS, NP
Medical Board Advisor
Known as “Nurse Barb” to legions of her television and blog followers, Ms. Dehn is the host of Nurse Barb’s Daily Dose which is broadcast throughout the country on ABC and The Live Well Network. She is a practicing women’s health nurse practitioner, award winning author and a nationally recognized health expert. Ms. Dehn holds a BS from Boston College and earned her master’s degree at the University of California, San Francisco. An in-demand and popular national speaker on all aspects of women’s health, she also lectures at Stanford and is a go-to health expert on television. She has appeared on CBS, CNN, Good Morning America Now and NBC’s iVillageLive. Nurse Barb’s first book, A Hot Guide to a Cool, Sexy Menopause (Basic Health Publications) was released in September 2014.
“Women are in great need of new technology, such as Cyrcadia Health’s, as we continue our efforts to bolster early breast cancer detection,” said Dehn. “This affordable and convenient Cyrcadia Health BodyMedia technology could provide a significant step towards meeting this goal. I am pleased to be a part of this endeavor and look forward to help introduce this innovative concept to patients and clinicians worldwide.”
Bonnie Rush, RT(R)(M)(QM)
Medical Board Advisor
Ms. Rush is a recognized expert in the breast imaging arena and the founder and president of Breast Imaging Specialists (BIS) of San Diego, Calif., a company focused on aiding imaging facilities to optimize their breast cancer early detection programs. Ms Rush was recognized by her imaging peers in an article titled “Working Wonders”, highlighting Bonnie’s dedication, expertise and involvement in the breast imaging arena.
Due to her ability to share salient information of value to imaging personnel, Bonnie is a requested speaker at local, regional and national imaging conferences. Ms. Rush authored the definitive explanation of the Mammography Quality Standards Act and is an expert witness in regulatory issues. She is considered an subject matter expert and is often quoted in breast imaging articles.
Her volunteer activities are numerous and have included many firsts including; establishing the first low-cost mammography screening program in San Diego, launching of the San Diego Breast Cancer Early Detection Program, founding the Mammography Society of San Diego and being named the first Director at Large in Mammography for her State Society.
Ms. Rush was personally impacted by dense breast tissue leading to a delayed diagnosis of invasive breast cancer in 2012. Her drive now is to advance early detection for all women with a special focus on “changing the destiny of those with breast density”. In that effort, she has added another first – first AHRA (Association of Medical Imaging Management) liaison to the Are You Dense Advocacy, Inc. to advance notification of the increased risk and masking of cancers in those with dense breasts.
Bonnie joined our company in order to reach her goal of optimizing early detection for all women. “I am so pleased to have this opportunity to work with such an extraordinary team of dedicated (and smart) individuals,” said Ms. Rush. “The goal is so exciting – the motivating driver to raise the bar on early detection and thus to save lives – with the appreciated potential of economic success. I could not ask for more positive reasons to say yes to join in this effort to advance this novel technology.”
Reno, NV 89502